13th Mar 2018 15:55
Motif Bio plc
("Motif Bio" or the "Company")
Change of Registered Office
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announces that it has changed its registered office address to 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT, with immediate effect.
For further information, please contact:
Motif Bio plc |
| |||||
Graham Lumsden (Chief Executive Officer) |
|
| ||||
Peel Hunt LLP (NOMAD & BROKER) | + 44 (0)20 7418 8900 |
| ||||
Dr Christopher Golden |
|
| ||||
Oliver Jackson |
|
| ||||
Northland Capital Partners Limited (BROKER) | +44 (0)203 861 6625 |
| ||||
David Hignell/John Howes/Rob Rees |
|
| ||||
Walbrook PR Ltd. (UK FINANCIAL PR & IR) | +44 (0) 20 7933 8780 |
| ||||
Paul McManus/Helen Cresswell/ |
|
| ||||
Lianne Cawthorne |
|
| ||||
MC Services AG (EUROPEAN IR) | +49 (0)89 210 2280 |
| ||||
Raimund Gabriel |
| |||||
The Trout Group (US IR) | + 1 (646) 378-2936 |
| ||||
Meggie Purcell |
| |||||
Russo Partners (US PR) | +1 (858) 717-2310 |
| ||||
David Schull |
| |||||
Travis Kruse, Ph.D. |
| |||||
|
|
|
|
| ||
Related Shares:
MTFB.L